BridgeBio Pharma (NASDAQ: BBIO) Just Broke Out on a HUGE Rival Setback – Could Rise 19%–30%
Plus, our recommended trade with VRT hit both price targets for a potential peak return of up to 52%.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 10, 2026
Plus, our recommended trade with VRT hit both price targets for a potential peak return of up to 52%.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 9, 2026
Plus, several stocks from our Top 10 Breakout Watchlist this week have already cleared their recommended buy levels.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 8, 2026
Plus, our recommended trade with VKTX touched our first price target to deliver a potential 19% return from entry in just under two weeks.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 7, 2026
Plus, our recommended trade with CLBT touched our first price target to deliver a potential 20% return from entry.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 6, 2026
Plus, our recommended trade with ABBV touched our first price target to deliver a potential 12% return from entry in under two weeks.
Read More
